By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Asterias Biotherapeutics 

230 Constitution Drive

Menlo Park  California  94025  U.S.A.
Phone: 650-433-2992 Fax: n/a



Company News
Asterias Biotherapeutics Reports Second Quarter Results And Highlights Progress Of Scistar Study Evaluating AST-OPC1 In Spinal Cord Injury Patients 8/16/2016 8:52:55 AM
Asterias Biotherapeutics To Report Second Quarter Results On August 15, 2016 8/1/2016 9:53:01 AM
Asterias Biotherapeutics Appoints Ryan Chavez As EVP Of Finance And General Counsel 7/18/2016 6:23:26 AM
Asterias Biotherapeutics Completes Enrollment And Dosing For The First Efficacy Cohort Of The AST-OPC1 Scistar Phase 1/2a Clinical Trial In Complete Cervical Spinal Cord Injury 7/12/2016 6:06:00 AM
Asterias Biotherapeutics Announces Oral Presentation And Participation In Panel Discussion At The ISSCR 14th Annual Meeting 6/21/2016 8:10:34 AM
Asterias Biotherapeutics Closes Exercise Of Over-Allotment Option In Connection With Its Previously Announced Public Offering 5/24/2016 7:37:00 AM
Asterias Biotherapeutics Announces Positive New Long-Term Follow-Up Results For AST-OPC1 5/24/2016 6:37:30 AM
Asterias Biotherapeutics Reports First Quarter Results 5/17/2016 6:51:47 AM
Asterias Biotherapeutics Announces Closing Of Public Offering Of Common Stock And Warrants, And Exercise Of Over-Allotment Option To Purchase Additional Warrants 5/13/2016 11:08:50 AM
Asterias Biotherapeutics To Report First Quarter Results On May 16, 2016 5/12/2016 6:42:26 AM